CANASA vs CYLTEZO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. CANASA and CYLTEZO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CANASA	CYLTEZO
Rating	72/100	72/100
Pharmacy pays	~$26.72 /30	—
Type	RX	RX
Active ingredient	MESALAMINE	ADALIMUMAB-ADBM
Manufacturer	Abbvie	Boehringer Ingelheim
Dosage forms	Suppository	Kit
Drug class	Aminosalicylate	—
Boxed warning	None	Boxed warning
Half-life	about 7 to 9 hours (apparent terminal half-life)	—
Treats	Ulcerative Colitis, Proctitis, Sigmoid Diseases	Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis

canasa cyltezo

Rating

72/100

Pharmacy pays

~$26.72 /30

—

Type

Active ingredient

MESALAMINE

ADALIMUMAB-ADBM

Manufacturer

Abbvie

Boehringer Ingelheim

Dosage forms

Suppository

Kit

Drug class

Aminosalicylate

—

Boxed warning

None

Boxed warning

Half-life

about 7 to 9 hours (apparent terminal half-life)

—

Treats

Ulcerative Colitis, Proctitis, Sigmoid Diseases

Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis

Frequently asked questions

Which is better-rated, Canasa or Cyltezo?

Canasa and Cyltezo are tied at 3.6 out of 5 by our independent rating.

What is the difference between Canasa and Cyltezo?

Canasa contains Mesalamine, while Cyltezo contains Adalimumab-Adbm — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.